Compare Exelixis (EX9) vs. Competitors

1 Followers

Comparison Results

EX9

Exelixis

€46.93

€12.90B

17.94

52.25%

3 Buy

9 Hold

1 Sell

Hold

Incyte

$128.12

$22.99B

13.87

32.06%

11 Buy

10 Hold

0 Sell

Moderate Buy

Jazz Pharmaceuticals

$260.23

$15.01B

14.63

61.45%

18 Buy

1 Hold

0 Sell

Strong Buy

Summit Therapeutics

$14.23

$14.36B

-15.33

-26.44%

10 Buy

6 Hold

0 Sell

Moderate Buy

Zai Lab

$26.82

$2.88B

-14.03

-26.36%

3 Buy

0 Hold

0 Sell

Strong Buy

Genmab

$34.36

$22.33B

27.62

10.11%

9 Buy

1 Hold

0 Sell

Strong Buy

xxxxxxxxxxxxx

EX9 vs GMAB

xxxxxxxxxxxxx

Performance Comparison

DE:EX9

Exelixis

51.43

18.64

56.85%

INCY

Incyte

112.75

28.00

33.04%

JAZZ

Jazz Pharmaceuticals

222.45

84.30

61.02%

SMMT

Summit Therapeutics

17.17

-5.48

-24.19%

ZLAB

Zai Lab

24.81

-7.89

-24.13%

GMAB

Genmab

36.05

4.20

13.19%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >